NotableLead sponsor: National Institute of Mental Health (NIMH) to University of California, Los Angelesv4Show 10 more changesShow less
Results first posted: Jun 10, 2015
Enrollment target: 160 to 107
Primary endpoints: 2 to 1
Primary completion date: Jun 2005
Study completion date: Sep 2005 to Sep 2006
Interventions: Individual Placement and Support (Behavioral), Olanzapine (Drug), Risperidone (Drug), Social Skills Training (Behavioral) to Individual Placement and Support (Supported Employment) (Behavioral), Olanzapine (Drug), Risperidone (Drug), Social Skills Training…
Collaborators expanded, about 11 words
Study arms: 0 to 4
Secondary endpoints expanded, about 3 words
Study title shortened, about 5 words
Re-verified, no change to tracked fieldsv3
NotablePrimary endpoints: 1 to 2v2Show 6 more changesShow less
Trial status: Active, Not Recruiting to Completed
Eligibility criteria expanded, about 19 words
Secondary endpoints shortened, about 11 words
Study sites revised (2)
Study description shortened, about 3 words
Study title expanded, about 3 words
Study First Submitted
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
This study will compare employment support with behavioral skills training to employment support alone in schizophrenia patients taking either risperidone or olanzapine to determine which is more effective in helping the patients maintain a job.